We show in this study that RhoB induction in control cell lines (OVCAR-3A and WT) and its inhibition in OVCAR-3LTE is critical in ovarian cell lines we used for migration capacities and certainly for tumour aggressiveness together induced by trastuzumab treatment. The gene discussed is RHOB; the disease is neoplasm.